Filing of bipartisan Senate bill boosts momentum for office of men’s health
Senate bill would commission a study on the state of men’s health in the U.S. — 'a growing health crisis,' says Sen. Ruben Gallego.
News Search
Search Results
Senate bill would commission a study on the state of men’s health in the U.S. — 'a growing health crisis,' says Sen. Ruben Gallego.
FDA panel meets this week to weigh whether to allow pharmacies to compound seven synthetic peptides amid concerns over safety and conflicts of interest.
More than a year after Trump promised reinstatement, hundreds remain bogged down in bureaucratic red tape, often over back pay and benefit questions.
The fastest Ebola outbreak in history has been further complicated as some health workers have gone on strike.
American hospitals are particularly vulnerable to the mythology of the indispensable physician or leader: the renowned surgeon, brilliant diagnostician.
WHO prefers vaccines that target Bundibugyo species of ebolaviruses. NEJM study says Merck's vaccine against Zaire variant may still offer some protection.
Results show the drug works well for weight loss, but the question of whether it can improve cardiovascular outcomes remains.
DTC television ads for medicines have become ubiquitous, with spending reaching $5.5 billion last year, up from $4.8 billion the year before.
After 18 months, President Trump nominates physician Timothy Westlake to lead SAMHSA, the federal agency overseeing mental health and addiction.
MDCalc is launching a quality-rating system to apply to the more than 800 clinical calculators doctors use to assess disease risk, transplant eligibility, and more.
The decision to roll out widespread population level testing in U.S. servicemembers represents a novel experiment with potential pitfalls, urologist writes.
New Medicare fee schedule proposals would increase physician pay for smoking cessation counseling, aiming to improve quit rates and chronic disease care.
New data from Biogen on its tau-lowering drug for Alzheimer’s raised questions that left experts and investors debating the drug’s future.
As smoke from Canadian wildfires blankets American skies, ER visits for asthma exacerbations jumped 31% in New York City.
STAT readers weigh in on controversial First Opinions on primary care, obesity as a disease, and more.
Suicide prevention group handled half the calls to the 988 crisis line's specialized service for LGBTQ+ youth before it was ended last year.
A Duchenne muscular dystrophy treatment too good to be true? Sonathera makes its case, and raises $125 million, despite questions about its unique method.
Defense Secretary wants low-T tests for service members 30 and over. While some experts lauded the plan, one specialist called idea 'crazy.'
MAHA believes that metabolic and environmental interventions can serve as the primary pillars of a national mental health strategy. That’s wrong.
Escorted out by security. Promised an investigation. Articles spiked. Here are the latest developments on a conference controversy that persists.
After a spinal cord injury left him paralyzed, Keith Thomas regained some movement and touch using a pioneering 'double neural bypass' brain implant.
Insurance giant UnitedHealth signals the cost of providing workers with health insurance will climb even higher.
Marburg spread in a region battling Ebola outbreak in neighboring DRC is unsettling. Angolan Marburg outbreak in 2024-25 saw 227 fatalities in 252 cases.
Democrats attempted to stop a test of AI-driven prior authorizations in Medicare, known as WISeR.